SELLAS Life Sciences Group (SLS)

SELLAS Life Sciences Group on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.

Download CSV

53.8M

Short interest

settlement 2026-10-15

11.9

Days to cover

+2.5 days vs prior

49.1%

Short share of volume

2026-11-02

9,606

Fails to deliver

settlement 2026-10-14

Wed 11 Nov

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in SLS is 53,759,252 shares, down 5,309,378 shares over the last month. Over the last 48 readings it ranged from 7,455,282 shares (13 December 2024) to 63,360,925 shares (15 June 2026). At the reported average volume of 4.5M shares a day that is 11.9 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/sls" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	53,759,252	-2.5%	4,498,881	11.95
2026-09-30	55,128,974	-6.7%	5,836,430	9.45
2026-09-15	59,068,630	+2.0%	6,865,048	8.60
2026-08-31	57,926,912	+2.8%	8,420,398	6.88
2026-08-14	56,371,865	+2.5%	5,401,984	10.44
2026-07-31	54,975,815	-0.6%	6,970,602	7.89
2026-07-15	55,280,869	-12.7%	9,327,034	5.93
2026-06-30	63,307,462	-0.1%	13,331,720	4.75
2026-06-15	63,360,925	+3.9%	6,852,581	9.25
2026-05-29	61,000,107	+6.9%	13,792,699	4.42
2026-05-15	57,070,692	-0.1%	7,994,700	7.14
2026-04-30	57,147,188	+0.9%	4,893,935	11.68
2026-04-15	56,642,215	+5.8%	4,155,540	13.63
2026-03-31	53,525,042	+16.9%	8,987,389	5.96
2026-03-13	45,790,317	-6.8%	7,332,194	6.25
2026-02-27	49,129,452	+6.7%	6,310,503	7.79
2026-02-13	46,050,545	+11.4%	4,601,439	10.01
2026-01-30	41,330,037	-1.7%	6,599,510	6.26
2026-01-15	42,044,430	-14.9%	16,240,884	2.59
2025-12-31	49,429,420	+22.1%	11,457,774	4.31
2025-12-15	40,466,622	+21.7%	5,725,599	7.07
2025-11-28	33,260,681	+4.6%	3,246,928	10.24
2025-11-14	31,792,641	+9.8%	3,572,403	8.90
2025-10-31	28,964,581	+15.4%	6,123,028	4.73
2025-10-15	25,093,376	+8.9%	3,490,044	7.19
2025-09-30	23,051,006	+10.3%	2,403,190	9.59
2025-09-15	20,889,586	-28.8%	1,895,794	11.02
2025-08-29	29,341,205	+0.7%	2,165,441	13.55
2025-08-15	29,152,537	+10.4%	1,505,486	19.36
2025-07-31	26,412,853	-4.8%	2,143,005	12.33
2025-07-15	27,735,843	+13.9%	3,552,834	7.81
2025-06-30	24,359,258	+28.9%	4,377,829	5.56
2025-06-13	18,897,977	+54.6%	2,350,500	8.04
2025-05-30	12,221,572	+39.6%	3,374,199	3.62
2025-05-15	8,756,643	+13.6%	2,618,993	3.34
2025-04-30	7,709,569	-0.8%	1,876,832	4.11
2025-04-15	7,774,815	-4.9%	1,148,851	6.77
2025-03-31	8,176,648	+4.2%	884,956	9.24
2025-03-14	7,845,644	+0.5%	895,158	8.76
2025-02-28	7,806,570	-9.8%	1,242,274	6.28
2025-02-14	8,652,314	-11.8%	2,504,746	3.45
2025-01-31	9,805,787	+8.9%	7,813,871	1.25
2025-01-15	8,999,899	+12.9%	1,499,331	6.00
2024-12-31	7,973,831	+7.0%	1,108,051	7.20
2024-12-13	7,455,282	-17.6%	2,122,983	3.51
2024-11-29	9,048,267	+3.2%	1,024,426	8.83
2024-11-15	8,765,519	+1.8%	784,881	11.17
2024-10-31	8,610,940	+41.5%	655,460	13.14

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of SLS volume is 49.1%, down 10.1 points over the last five sessions. Over the last 30 readings it ranged from 46.2% (27 October 2026) to 73.9% (28 October 2026). The latest reading is 10.9 points below the 30-session average of 60.0%, on 6.7M shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	3.3M	6.7M	49.1%	362,368
2026-10-30	1.8M	3.0M	59.6%	20,813
2026-10-29	2.4M	4.1M	59.4%	439,890
2026-10-28	8.8M	11.9M	73.9%	1,145,415
2026-10-27	1.4M	3.0M	46.2%	19,098
2026-10-26	886K	1.5M	59.2%	13,730
2026-10-23	1.0M	1.7M	60.8%	445
2026-10-22	2.2M	3.5M	61.2%	20,134
2026-10-21	1.8M	3.1M	57.6%	17,221
2026-10-20	2.6M	5.0M	51.0%	23,113
2026-10-19	1.6M	2.7M	60.6%	241,821
2026-10-16	5.1M	7.5M	67.1%	633,100
2026-10-15	1.5M	2.6M	57.2%	5,706
2026-10-14	1.2M	2.1M	57.5%	23,889
2026-10-13	2.1M	3.1M	66.6%	26,436
2026-10-12	1.2M	2.0M	61.3%	2,410
2026-10-09	1.1M	1.9M	57.2%	8,798
2026-10-08	1.3M	2.2M	60.0%	4,682
2026-10-07	830K	1.4M	57.7%	11
2026-10-06	1.3M	1.9M	64.9%	1,749
2026-10-05	1.3M	2.6M	50.0%	7,451
2026-10-02	1.1M	1.8M	60.0%	24
2026-10-01	2.2M	3.0M	72.0%	261
2026-09-30	2.5M	4.1M	61.3%	14,881
2026-09-29	835K	1.4M	61.6%	0
2026-09-28	925K	1.7M	53.8%	0
2026-09-25	1.3M	2.2M	61.2%	8,959
2026-09-24	1.4M	2.3M	62.1%	14,908
2026-09-23	1.3M	1.9M	69.2%	15,338
2026-09-22	1.8M	3.0M	60.4%	6,548

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 14 October 2026, the fails-to-deliver balance in SLS is 9,606 shares, down 26,431 shares over the last settlement date. Over the last 30 readings it ranged from 855 shares (11 September 2026) to 403,160 shares (1 September 2026). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-10-14	9,606	$12.41	$119K
2026-10-13	36,037	$11.93	$430K
2026-10-09	3,723	$11.26	$42K
2026-10-08	60,660	$11.31	$686K
2026-10-07	81,143	$11.34	$920K
2026-10-06	4,923	$11.63	$57K
2026-10-05	139,017	$11.74	$1.6M
2026-10-02	145,120	$11.33	$1.6M
2026-10-01	135,200	$12.31	$1.7M
2026-09-30	2,545	$11.51	$29K
2026-09-29	1,024	$11.59	$12K
2026-09-25	17,303	$11.98	$207K
2026-09-24	40,679	$11.52	$469K
2026-09-23	9,737	$12.02	$117K
2026-09-22	34,249	$11.37	$389K
2026-09-21	140,822	$11.49	$1.6M
2026-09-18	108,639	$11.53	$1.3M
2026-09-17	5,310	$11.66	$62K
2026-09-16	6,990	$11.29	$79K
2026-09-15	121,577	$11.73	$1.4M
2026-09-14	990	$11.55	$11K
2026-09-11	855	$13.49	$12K
2026-09-10	11,559	$13.95	$161K
2026-09-09	66,656	$13.96	$931K
2026-09-08	95,897	$13.86	$1.3M
2026-09-04	74,952	$13.70	$1.0M
2026-09-03	159,411	$14.16	$2.3M
2026-09-02	180,239	$13.22	$2.4M
2026-09-01	403,160	$13.34	$5.4M
2026-08-31	369,763	$13.21	$4.9M

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for SLS in the last 90 days. The most recent filings are listed below. Latest filing: Stergiou Angelos M. (President and CEO) on 2026-06-16.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-06-16	Stergiou Angelos M.	President and CEO	Grant	1.1M	$0.00	$0	1.8M
2026-01-07	Varian John	Director	Grant	50K	$0.00	$0	73K
2026-01-07	VAN NOSTRAND ROBERT L	Director	Grant	50K	$0.00	$0	83K
2026-01-07	Wasman Jane	Director	Grant	50K	$0.00	$0	93K
2026-01-07	SCHEINBERG DAVID A	Director	Grant	50K	$0.00	$0	73K
2026-01-07	Kalin Katherine Bach	Director	Grant	50K	$0.00	$0	154K
2026-01-07	CICIC DRAGAN	SVP, Chief Development Officer	Grant	300K	$0.00	$0	558K
2026-01-07	Burns John Thomas	CFO	Grant	300K	$0.00	$0	554K
2025-12-03	Stergiou Angelos M.	President and CEO	Other transaction	187K	$1.50	$281K	687K
2025-12-03	CICIC DRAGAN	SVP, Chief Development Officer	Other transaction	64K	$1.50	$96K	258K
2025-12-03	Burns John Thomas	CFO	Other transaction	59K	$1.50	$88K	254K
2025-11-19	Kalin Katherine Bach	Director	Buy	63K	$1.59	$101K	104K
2025-06-12	VAN NOSTRAND ROBERT L	Director	Buy	10K	$1.48	$15K	20K
2025-05-30	Wasman Jane	Director	Buy	20K	$1.69	$34K	30K
2025-05-22	Kalin Katherine Bach	Director	Buy	20K	$1.80	$36K	41K
2025-01-10	CICIC DRAGAN	SVP, Chief Development Officer	Grant	113K	$0.00	$0	228K
2025-01-10	CICIC DRAGAN	SVP, Chief Development Officer	Grant	81K	$0.00	$0	310K
2025-01-10	Varian John	Director	Grant	13K	$0.00	$0	23K
2025-01-10	Kalin Katherine Bach	Director	Grant	13K	$0.00	$0	21K
2025-01-10	VAN NOSTRAND ROBERT L	Director	Grant	13K	$0.00	$0	23K
2025-01-10	Wasman Jane	Director	Grant	13K	$0.00	$0	23K
2025-01-10	SCHEINBERG DAVID A	Director	Grant	13K	$0.00	$0	23K
2025-01-10	Stergiou Angelos M.	President and CEO	Grant	257K	$0.00	$0	615K
2025-01-10	Stergiou Angelos M.	President and CEO	Grant	244K	$0.00	$0	859K
2025-01-10	Burns John Thomas	CFO	Grant	81K	$0.00	$0	299K
2025-01-10	Burns John Thomas	CFO	Grant	113K	$0.00	$0	218K
2024-12-04	Burns John Thomas	CFO	Other transaction	7K	$1.13	$8K	105K
2024-12-04	Stergiou Angelos M.	President and CEO	Other transaction	28K	$1.13	$32K	358K
2024-12-04	CICIC DRAGAN	SVP, Chief Development Officer	Other transaction	8K	$1.13	$9K	115K
2024-01-22	Burns John Thomas	CFO	Grant	47K	$0.00	$0	102K
2024-01-22	VAN NOSTRAND ROBERT L	Director	Grant	6K	$0.00	$0	10K
2024-01-22	Varian John	Director	Grant	6K	$0.00	$0	10K
2024-01-22	Francomano Robert	Chief Commercial Officer	Grant	20K	$0.00	$0	41K
2024-01-22	Wasman Jane	Director	Grant	6K	$0.00	$0	10K
2024-01-22	Kalin Katherine Bach	Director	Grant	6K	$0.00	$0	9K
2024-01-22	WOOD BARBARA A	EVP, Gen. Counsel, Corp. Sec.	Grant	35K	$0.00	$0	117K
2024-01-22	SCHEINBERG DAVID A	Director	Grant	6K	$0.00	$0	11K
2024-01-22	Stergiou Angelos M.	President and CEO	Grant	159K	$0.00	$0	376K
2023-12-06	Burns John Thomas	CFO	Other transaction	3K	$1.08	$3K	55K
2023-12-06	Francomano Robert	Chief Commercial Officer	Other transaction	1K	$1.08	$1K	21K
2023-12-06	Stergiou Angelos M.	President and CEO	Other transaction	12K	$1.08	$13K	217K
2023-12-06	WOOD BARBARA A	EVP, Gen. Counsel, Corp. Sec.	Other transaction	4K	$1.08	$4K	82K
2023-02-02	Kalin Katherine Bach	Director	Grant	3K	$0.00	$0	3K
2023-02-02	SCHEINBERG DAVID A	Director	Grant	3K	$0.00	$0	5K
2023-02-02	VAN NOSTRAND ROBERT L	Director	Grant	3K	$0.00	$0	4K
2023-02-02	Wasman Jane	Director	Grant	3K	$0.00	$0	4K
2023-02-02	Varian John	Director	Grant	3K	$0.00	$0	4K
2023-02-02	Francomano Robert	Chief Commercial Officer	Grant	12K	$0.00	$0	12K
2023-02-02	Stergiou Angelos M.	President and CEO	Grant	58K	$0.00	$0	220K
2023-02-02	Burns John Thomas	CFO	Grant	20K	$0.00	$0	49K
2023-02-02	WOOD BARBARA A	EVP, Gen. Counsel, Corp. Sec.	Grant	20K	$0.00	$0	76K
2022-12-05	WOOD BARBARA A	EVP, Gen. Counsel, Corp. Sec.	Sell	2K	$2.59	$6K	56K
2022-12-05	Burns John Thomas	Senior VP, Finance & CAO	Sell	1K	$2.59	$3K	29K
2022-12-05	Stergiou Angelos M.	President and CEO	Sell	6K	$2.61	$17K	162K
2022-01-31	Burns John Thomas	Senior VP, Finance & CAO	Grant	10K	$0.00	$0	27K
2022-01-31	SCHEINBERG DAVID A	Director	Grant	2K	$0.00	$0	2K
2022-01-31	Stergiou Angelos M.	President and CEO	Grant	44K	$0.00	$0	165K
2022-01-31	VAN NOSTRAND ROBERT L	Director	Grant	2K	$0.00	$0	2K
2022-01-31	Varian John	Director	Grant	2K	$0.00	$0	2K
2022-01-31	Wasman Jane	Director	Grant	2K	$0.00	$0	2K
2022-01-31	WOOD BARBARA A	EVP, Gen. Counsel, Corp. Sec.	Grant	13K	$0.00	$0	55K
2021-12-02	Burns John Thomas	VP, Finance & Corp Controller	Sell	231	$6.27	$1K	18K
2021-12-02	WOOD BARBARA A	EVP, Gen. Counsel, Corp. Sec.	Sell	847	$6.25	$5K	42K
2021-12-02	Stergiou Angelos M.	President and CEO	Sell	2K	$6.25	$13K	121K
2021-03-04	Stergiou Angelos M.	President and CEO	Grant	20K	$0.00	$0	98K
2021-03-04	Burns John Thomas	VP, Finance & Corp Controller	Grant	3K	$0.00	$0	13K
2021-03-04	WOOD BARBARA A	EVP, Gen. Counsel, Corp. Sec.	Grant	8K	$0.00	$0	33K
2020-03-12	Burns John Thomas	VP, Finance & Corp Controller	Grant	15K	$0.00	$0	15K
2020-03-12	Stergiou Angelos M.	President and CEO	Grant	95K	$0.00	$0	95K
2020-03-12	WOOD BARBARA A	EVP, Gen. Counsel, Corp. Sec.	Grant	35K	$0.00	$0	35K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

3 holders report 5% or more of SLS in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 7.9% of the class (15,872,685 shares), filed 2026-10-27 for an event on 2026-09-30.

Filed	Form	Holder	Shares	Of class	Event
2026-10-27	13G/Ano. 2	BlackRock, Inc.parent holding company	15.9M	7.9%	2026-09-30
2026-08-07	13G	STATE STREET CORPORATIONparent holding company	13.0M	7.0%	2026-06-30
2026-07-31	13G	Vanguard Capital Managementinvestment adviser	9.7M	5.2%	2026-06-30
2026-03-27	13G/Ano. 1	The Vanguard Groupinvestment adviser	0	0.0%	2026-03-13
2026-02-17	13G/Ano. 1	Anson Funds Management LPinvestment adviser, partnership	7.5M	4.9%	2025-12-31
2026-02-17	13G/Ano. 1	Anson Management GP LLCparent holding company, other entity	7.5M	4.9%	2025-12-31
2026-02-17	13G/Ano. 1	Tony Mooreparent holding company, individual	7.5M	4.9%	2025-12-31
2026-02-17	13G/Ano. 1	Anson Advisors Inc.non-US institution, corporation	7.5M	4.9%	2025-12-31
2026-02-17	13G/Ano. 1	Amin Nathooparent holding company, individual	7.5M	4.9%	2025-12-31
2026-02-17	13G/Ano. 1	Moez Kassamparent holding company, individual	7.5M	4.9%	2025-12-31
2026-01-30	13G/Ano. 2	Highbridge Capital Management, LLCinvestment adviser, other entity	6.5M	3.7%	2025-12-31

13F holders

Tracked managers holding SLS at their latest 13F. JSON

2 of the 30 tracked managers held SLS at their latest 13F, $5.4M in total at quarter-end prices. Renaissance Technologies is the largest at $4.6M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 0 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Renaissance Technologies	2026-06-30	310K	$4.6M	0.01%	new
AQR Capital Management	2026-06-30	58K	$858K	0.00%	+4K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

Financials

SEC XBRL, as filed. JSON

In FY 2025 it generated -$28.4M of operating cash flow.

Cash: $138.3M
Equity: $137.7M
Total assets: $145.4M
Shares outstanding: 201,945,709

Quarterly, last 8 quarters

Quarter	Period end	Revenue	Net income	Margin	Diluted EPS
Q2 FY 2026	2026-06-30	n/a	-$9.6M	n/a	-0.05
Q1 FY 2026	2026-03-31	n/a	-$8.4M	n/a	-0.05
Q4 FY 2025derived	2025-12-31	n/a	-$7.7M	n/a	n/a
Q3 FY 2025	2025-09-30	n/a	-$6.8M	n/a	-0.06
Q2 FY 2025	2025-06-30	n/a	-$6.6M	n/a	-0.07
Q1 FY 2025	2025-03-31	n/a	-$5.8M	n/a	-0.07
Q4 FY 2024derived	2024-12-31	n/a	-$6.7M	n/a	n/a
Q3 FY 2024	2024-09-30	n/a	-$7.1M	n/a	-0.10

Fiscal years, with buybacks and dividends

Fiscal year	Ends	Revenue	Net income	Operating cash flow	Capex	Buybacks	Dividends
FY 2025	2025-12-31	n/a	-$26.9M	-$28.4M	n/a	n/a	n/a
FY 2024	2024-12-31	n/a	-$30.9M	-$35.4M	n/a	n/a	n/a
FY 2023	2023-12-31	$0	-$37.3M	-$31.4M	n/a	n/a	n/a
FY 2022	2022-12-31	$1.0M	-$41.3M	-$23.8M	n/a	n/a	n/a
FY 2021	2021-12-31	$7.6M	-$20.7M	-$26.0M	n/a	n/a	n/a

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-10 from the cover page.

What this page is

SELLAS Life Sciences Group in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows SELLAS Life Sciences Group (SLS), SEC CIK 1390478, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-27.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Financials: SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-11.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-16.JSON and CSV
Company record: EDGAR filing index for CIK 1390478Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other companies the SEC classifies as pharmaceutical preparations

Other company pages

Datasets

Frequently Asked Questions

How much of SLS is sold short?

53,759,252 shares were held short at the 2026-10-15 settlement, 11.9 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is SLS's daily short volume?

On 2026-11-02, 3,302,550 of the 6,727,446 SLS shares reported to FINRA were sold short, 49.1% of the day's reported volume. Short volume is a flow for one day, not a position.

Does SLS have fails to deliver?

The SEC's latest file shows 9,606 SLS shares failed to deliver at settlement 2026-10-14. Fails are reported per settlement date and published twice a month with a lag.

Are SLS insiders buying or selling?

No open-market insider trades were reported for SLS in the last 90 days. The most recent filings are listed below. Latest filing: Stergiou Angelos M. (President and CEO) on 2026-06-16.

Who owns 5% or more of SLS?

What did SLS report last quarter?

In FY 2025 it generated -$28.4M of operating cash flow.

Which tracked 13F managers own SLS?

2 of the 30 tracked 13F managers held SLS shares at their latest filing, $5.4M in all. The largest: Renaissance Technologies (310K shares, $4.6M), Cliff Asness's AQR Capital Management (58K shares, $858K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.